Fig. 1From: Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetesThe relationship between lnFGF19 and baPWV in patients with T2D (a unadjusted; b partially adjusted for age, gender, duration, BMI, hypertension, diabetic treatments, NAFLD)Back to article page